Study: Aspirin cuts mortality risk after CRC diagnosis

04/25/2012 | BBC

A study of colorectal cancer patients in the Netherlands found those who took a daily low dose of aspirin for at least nine months after their diagnosis reduced their mortality risk by 30%, according to Leiden University Medical Centre research. "Our work adds to growing evidence that aspirin not only can prevent cancer from occurring but if it is there it can help prevent it spreading," said Dr. Gerrit-Jan Liefers, lead author of the study.

View Full Article in:


Published in Briefs: